APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alpha N-Acetylglucosaminidase

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Alpha N-Acetylglucosaminidase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025189 pages

Choose your research edition.

Industry ResearchAlpha N-Acetylglucosaminidase Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Alpha N-Acetylglucosaminidase Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Alpha N-Acetylglucosaminidase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alpha N-Acetylglucosaminidase Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Alpha N-Acetylglucosaminidase Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Alpha N-Acetylglucosaminidase market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Alpha N-Acetylglucosaminidase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Alpha N-Acetylglucosaminidase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Alpha N-Acetylglucosaminidase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Alpha N-Acetylglucosaminidase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Alpha N-Acetylglucosaminidase include UniQure N.V., Laboratorios Del Dr. Esteve S.A., Dorphan S.A., BioMarin Pharmaceutical Inc., Alexion Pharmaceuticals, Inc. and Abeona Therapeutics, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Alpha N-Acetylglucosaminidase market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Alpha N-Acetylglucosaminidase and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Alpha N-Acetylglucosaminidase sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Alpha N-Acetylglucosaminidase market size, projected growth trends, production technologies, key applications, and end-use industries.

Alpha N-Acetylglucosaminidase Segment by Company

UniQure N.V.

Laboratorios Del Dr. Esteve S.A.

Dorphan S.A.

BioMarin Pharmaceutical Inc.

Alexion Pharmaceuticals, Inc.

Abeona Therapeutics, Inc.

Alpha N-Acetylglucosaminidase Segment by Type

Lesinidase Alfa

EGT-201

BMN-250

ABO-101

Others

Alpha N-Acetylglucosaminidase Segment by Application

In-Patient

Out-Patient

Alpha N-Acetylglucosaminidase Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alpha N-Acetylglucosaminidase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alpha N-Acetylglucosaminidase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alpha N-Acetylglucosaminidase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Alpha N-Acetylglucosaminidase market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Alpha N-Acetylglucosaminidase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Alpha N-Acetylglucosaminidase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Alpha N-Acetylglucosaminidase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Alpha N-Acetylglucosaminidase Industry Trends Table 2. Alpha N-Acetylglucosaminidase Industry Drivers Table 3. Alpha N-Acetylglucosaminidase Industry Opportunities and Challenges Table 4. Alpha N-Acetylglucosaminidase Industry Restraints Table 5. Global Alpha N-Acetylglucosaminidase Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Alpha N-Acetylglucosaminidase Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Alpha N-Acetylglucosaminidase Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Alpha N-Acetylglucosaminidase Sales Market Share by Manufacturers Table 9. Global Alpha N-Acetylglucosaminidase Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Alpha N-Acetylglucosaminidase Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Alpha N-Acetylglucosaminidase Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Alpha N-Acetylglucosaminidase Manufacturers, Product Type & Application Table 13. Global Alpha N-Acetylglucosaminidase Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Alpha N-Acetylglucosaminidase by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Lesinidase Alfa Table 17. Major Manufacturers of EGT-201 Table 18. Major Manufacturers of BMN-250 Table 19. Major Manufacturers of ABO-101 Table 20. Major Manufacturers of Others Table 21. Global Alpha N-Acetylglucosaminidase Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Alpha N-Acetylglucosaminidase Sales by Type (2021-2026) & (K Units) Table 23. Global Alpha N-Acetylglucosaminidase Sales by Type (2027-2032) & (K Units) Table 24. Global Alpha N-Acetylglucosaminidase Sales Market Share by Type (2021-2026) Table 25. Global Alpha N-Acetylglucosaminidase Sales Market Share by Type (2027-2032) Table 26. Global Alpha N-Acetylglucosaminidase Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Alpha N-Acetylglucosaminidase Revenue by Type (2021-2026) & (K Units) Table 28. Global Alpha N-Acetylglucosaminidase Revenue by Type (2027-2032) & (K Units) Table 29. Global Alpha N-Acetylglucosaminidase Revenue Market Share by Type (2021-2026) Table 30. Global Alpha N-Acetylglucosaminidase Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of In-Patient Table 32. Major Manufacturers of Out-Patient Table 33. Global Alpha N-Acetylglucosaminidase Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Alpha N-Acetylglucosaminidase Sales by Application (2021-2026) & (K Units) Table 35. Global Alpha N-Acetylglucosaminidase Sales by Application (2027-2032) & (K Units) Table 36. Global Alpha N-Acetylglucosaminidase Sales Market Share by Application (2021-2026) Table 37. Global Alpha N-Acetylglucosaminidase Sales Market Share by Application (2027-2032) Table 38. Global Alpha N-Acetylglucosaminidase Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Alpha N-Acetylglucosaminidase Revenue by Application (2021-2026) & (K Units) Table 40. Global Alpha N-Acetylglucosaminidase Revenue by Application (2027-2032) & (K Units) Table 41. Global Alpha N-Acetylglucosaminidase Revenue Market Share by Application (2021-2026) Table 42. Global Alpha N-Acetylglucosaminidase Revenue Market Share by Application (2027-2032) Table 43. Global Alpha N-Acetylglucosaminidase Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Alpha N-Acetylglucosaminidase Sales by Region (2021-2026) & (K Units) Table 45. Global Alpha N-Acetylglucosaminidase Sales Market Share by Region (2021-2026) Table 46. Global Alpha N-Acetylglucosaminidase Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Alpha N-Acetylglucosaminidase Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Alpha N-Acetylglucosaminidase Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Alpha N-Acetylglucosaminidase Sales by Country (2021-2026) & (K Units) Table 50. North America Alpha N-Acetylglucosaminidase Sales by Country (2027-2032) & (K Units) Table 51. Europe Alpha N-Acetylglucosaminidase Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Alpha N-Acetylglucosaminidase Sales by Country (2021-2026) & (K Units) Table 53. Europe Alpha N-Acetylglucosaminidase Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Alpha N-Acetylglucosaminidase Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Alpha N-Acetylglucosaminidase Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Alpha N-Acetylglucosaminidase Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Alpha N-Acetylglucosaminidase Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Alpha N-Acetylglucosaminidase Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Alpha N-Acetylglucosaminidase Sales by Country (2027-2032) & (K Units) Table 60. Global Alpha N-Acetylglucosaminidase Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Alpha N-Acetylglucosaminidase Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Alpha N-Acetylglucosaminidase Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Alpha N-Acetylglucosaminidase Revenue Market Share by Region (2021-2026) Table 64. Global Alpha N-Acetylglucosaminidase Revenue Market Share by Region (2027-2032) Table 65. UniQure N.V. Company Information Table 66. UniQure N.V. Business Overview Table 67. UniQure N.V. Alpha N-Acetylglucosaminidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. UniQure N.V. Alpha N-Acetylglucosaminidase Product Portfolio Table 69. UniQure N.V. Recent Development Table 70. Laboratorios Del Dr. Esteve S.A. Company Information Table 71. Laboratorios Del Dr. Esteve S.A. Business Overview Table 72. Laboratorios Del Dr. Esteve S.A. Alpha N-Acetylglucosaminidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Laboratorios Del Dr. Esteve S.A. Alpha N-Acetylglucosaminidase Product Portfolio Table 74. Laboratorios Del Dr. Esteve S.A. Recent Development Table 75. Dorphan S.A. Company Information Table 76. Dorphan S.A. Business Overview Table 77. Dorphan S.A. Alpha N-Acetylglucosaminidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Dorphan S.A. Alpha N-Acetylglucosaminidase Product Portfolio Table 79. Dorphan S.A. Recent Development Table 80. BioMarin Pharmaceutical Inc. Company Information Table 81. BioMarin Pharmaceutical Inc. Business Overview Table 82. BioMarin Pharmaceutical Inc. Alpha N-Acetylglucosaminidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. BioMarin Pharmaceutical Inc. Alpha N-Acetylglucosaminidase Product Portfolio Table 84. BioMarin Pharmaceutical Inc. Recent Development Table 85. Alexion Pharmaceuticals, Inc. Company Information Table 86. Alexion Pharmaceuticals, Inc. Business Overview Table 87. Alexion Pharmaceuticals, Inc. Alpha N-Acetylglucosaminidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Alexion Pharmaceuticals, Inc. Alpha N-Acetylglucosaminidase Product Portfolio Table 89. Alexion Pharmaceuticals, Inc. Recent Development Table 90. Abeona Therapeutics, Inc. Company Information Table 91. Abeona Therapeutics, Inc. Business Overview Table 92. Abeona Therapeutics, Inc. Alpha N-Acetylglucosaminidase Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Abeona Therapeutics, Inc. Alpha N-Acetylglucosaminidase Product Portfolio Table 94. Abeona Therapeutics, Inc. Recent Development Table 95. Key Raw Materials Table 96. Raw Materials Key Suppliers Table 97. Alpha N-Acetylglucosaminidase Distributors List Table 98. Alpha N-Acetylglucosaminidase Customers List Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Alpha N-Acetylglucosaminidase Product Image Figure 2. Global Alpha N-Acetylglucosaminidase Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alpha N-Acetylglucosaminidase Market Size (2021-2032) & (US$ Million) Figure 4. Global Alpha N-Acetylglucosaminidase Sales (2021-2032) & (K Units) Figure 5. Global Alpha N-Acetylglucosaminidase Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Alpha N-Acetylglucosaminidase Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Lesinidase Alfa Image Figure 9. EGT-201 Image Figure 10. BMN-250 Image Figure 11. ABO-101 Image Figure 12. Others Image Figure 13. Global Alpha N-Acetylglucosaminidase Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Alpha N-Acetylglucosaminidase Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Alpha N-Acetylglucosaminidase Sales Market Share by Type (2021-2032) Figure 16. Global Alpha N-Acetylglucosaminidase Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Alpha N-Acetylglucosaminidase Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Alpha N-Acetylglucosaminidase Revenue Market Share by Type (2021-2032) Figure 19. In-Patient Image Figure 20. Out-Patient Image Figure 21. Global Alpha N-Acetylglucosaminidase Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Alpha N-Acetylglucosaminidase Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Alpha N-Acetylglucosaminidase Sales Market Share by Application (2021-2032) Figure 24. Global Alpha N-Acetylglucosaminidase Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Alpha N-Acetylglucosaminidase Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Alpha N-Acetylglucosaminidase Revenue Market Share by Application (2021-2032) Figure 27. North America Alpha N-Acetylglucosaminidase Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Alpha N-Acetylglucosaminidase Sales Market Share by Country (2021-2032) Figure 29. U.S. Alpha N-Acetylglucosaminidase Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Alpha N-Acetylglucosaminidase Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Alpha N-Acetylglucosaminidase Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Alpha N-Acetylglucosaminidase Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Alpha N-Acetylglucosaminidase Sales Market Share by Country (2021-2032) Figure 34. Germany Alpha N-Acetylglucosaminidase Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Alpha N-Acetylglucosaminidase Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Alpha N-Acetylglucosaminidase Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Alpha N-Acetylglucosaminidase Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Alpha N-Acetylglucosaminidase Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Alpha N-Acetylglucosaminidase Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Alpha N-Acetylglucosaminidase Sales Market Share by Country (2021-2032) Figure 41. China Alpha N-Acetylglucosaminidase Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Alpha N-Acetylglucosaminidase Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Alpha N-Acetylglucosaminidase Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Alpha N-Acetylglucosaminidase Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Alpha N-Acetylglucosaminidase Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Alpha N-Acetylglucosaminidase Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Alpha N-Acetylglucosaminidase Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Alpha N-Acetylglucosaminidase Sales Market Share by Country (2021-2032) Figure 49. Brazil Alpha N-Acetylglucosaminidase Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Alpha N-Acetylglucosaminidase Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Alpha N-Acetylglucosaminidase Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Alpha N-Acetylglucosaminidase Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Alpha N-Acetylglucosaminidase Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Alpha N-Acetylglucosaminidase Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Alpha N-Acetylglucosaminidase Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Alpha N-Acetylglucosaminidase Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Alpha N-Acetylglucosaminidase Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Alpha N-Acetylglucosaminidase Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Alpha N-Acetylglucosaminidase Revenue (2021-2032) & (US$ Million) Figure 60. North America Alpha N-Acetylglucosaminidase Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Alpha N-Acetylglucosaminidase Revenue (2021-2032) & (US$ Million) Figure 62. Europe Alpha N-Acetylglucosaminidase Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Alpha N-Acetylglucosaminidase Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Alpha N-Acetylglucosaminidase Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Alpha N-Acetylglucosaminidase Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Alpha N-Acetylglucosaminidase Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Alpha N-Acetylglucosaminidase Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Alpha N-Acetylglucosaminidase Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Lesinidase Alfa
  • EGT-201
  • BMN-250
  • ABO-101
  • Others
Applications
  • In-Patient
  • Out-Patient
Companies covered
  • UniQure N.V.
  • Laboratorios Del Dr. Esteve S.A.
  • Dorphan S.A.
  • BioMarin Pharmaceutical Inc.
  • Alexion Pharmaceuticals, Inc.
  • Abeona Therapeutics, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Alpha N-Acetylglucosaminidase Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Alpha N-Acetylglucosaminidase Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Alpha N-Acetylglucosaminidase Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Alpha N-Acetylglucosaminidase Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Alpha N-Acetylglucosaminidase Market Dynamics
  1. 2.1 Alpha N-Acetylglucosaminidase Industry Trends
  2. 2.2 Alpha N-Acetylglucosaminidase Industry Drivers
  3. 2.3 Alpha N-Acetylglucosaminidase Industry Opportunities and Challenges
  4. 2.4 Alpha N-Acetylglucosaminidase Industry Restraints
3 Alpha N-Acetylglucosaminidase Market by Manufacturers
  1. 3.1 Global Alpha N-Acetylglucosaminidase Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Alpha N-Acetylglucosaminidase Sales by Manufacturers (2021-2026)
  3. 3.3 Global Alpha N-Acetylglucosaminidase Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Alpha N-Acetylglucosaminidase Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Alpha N-Acetylglucosaminidase Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Alpha N-Acetylglucosaminidase Manufacturers, Product Type & Application
  7. 3.7 Global Alpha N-Acetylglucosaminidase Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Alpha N-Acetylglucosaminidase Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Alpha N-Acetylglucosaminidase Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Alpha N-Acetylglucosaminidase Tier 1, Tier 2, and Tier 3
4 Alpha N-Acetylglucosaminidase Market by Type
  1. 4.1 Alpha N-Acetylglucosaminidase Type Introduction
  2. 4.1.1 Lesinidase Alfa
  3. 4.1.2 EGT-201
  4. 4.1.3 BMN-250
  5. 4.1.4 ABO-101
  6. 4.1.5 Others
  7. 4.2 Global Alpha N-Acetylglucosaminidase Sales by Type
  8. 4.2.1 Global Alpha N-Acetylglucosaminidase Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Alpha N-Acetylglucosaminidase Sales by Type (2021-2032)
  10. 4.2.3 Global Alpha N-Acetylglucosaminidase Sales Market Share by Type (2021-2032)
  11. 4.3 Global Alpha N-Acetylglucosaminidase Revenue by Type
  12. 4.3.1 Global Alpha N-Acetylglucosaminidase Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Alpha N-Acetylglucosaminidase Revenue by Type (2021-2032)
  14. 4.3.3 Global Alpha N-Acetylglucosaminidase Revenue Market Share by Type (2021-2032)
5 Alpha N-Acetylglucosaminidase Market by Application
  1. 5.1 Alpha N-Acetylglucosaminidase Application Introduction
  2. 5.1.1 In-Patient
  3. 5.1.2 Out-Patient
  4. 5.2 Global Alpha N-Acetylglucosaminidase Sales by Application
  5. 5.2.1 Global Alpha N-Acetylglucosaminidase Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Alpha N-Acetylglucosaminidase Sales by Application (2021-2032)
  7. 5.2.3 Global Alpha N-Acetylglucosaminidase Sales Market Share by Application (2021-2032)
  8. 5.3 Global Alpha N-Acetylglucosaminidase Revenue by Application
  9. 5.3.1 Global Alpha N-Acetylglucosaminidase Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Alpha N-Acetylglucosaminidase Revenue by Application (2021-2032)
  11. 5.3.3 Global Alpha N-Acetylglucosaminidase Revenue Market Share by Application (2021-2032)
6 Global Alpha N-Acetylglucosaminidase Sales by Region
  1. 6.1 Global Alpha N-Acetylglucosaminidase Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Alpha N-Acetylglucosaminidase Sales by Region (2021-2032)
  3. 6.2.1 Global Alpha N-Acetylglucosaminidase Sales by Region (2021-2026)
  4. 6.2.2 Global Alpha N-Acetylglucosaminidase Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Alpha N-Acetylglucosaminidase Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Alpha N-Acetylglucosaminidase Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Alpha N-Acetylglucosaminidase Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Alpha N-Acetylglucosaminidase Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Alpha N-Acetylglucosaminidase Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Alpha N-Acetylglucosaminidase Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Alpha N-Acetylglucosaminidase Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Alpha N-Acetylglucosaminidase Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Alpha N-Acetylglucosaminidase Revenue by Region
  1. 7.1 Global Alpha N-Acetylglucosaminidase Revenue by Region
  2. 7.1.1 Global Alpha N-Acetylglucosaminidase Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Alpha N-Acetylglucosaminidase Revenue by Region (2021-2026)
  4. 7.1.3 Global Alpha N-Acetylglucosaminidase Revenue by Region (2027-2032)
  5. 7.1.4 Global Alpha N-Acetylglucosaminidase Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Alpha N-Acetylglucosaminidase Revenue (2021-2032)
  8. 7.2.2 North America Alpha N-Acetylglucosaminidase Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Alpha N-Acetylglucosaminidase Revenue (2021-2032)
  11. 7.3.2 Europe Alpha N-Acetylglucosaminidase Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Alpha N-Acetylglucosaminidase Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Alpha N-Acetylglucosaminidase Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Alpha N-Acetylglucosaminidase Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Alpha N-Acetylglucosaminidase Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 UniQure N.V.
  2. 8.1.1 UniQure N.V. Company Information
  3. 8.1.2 UniQure N.V. Business Overview
  4. 8.1.3 UniQure N.V. Alpha N-Acetylglucosaminidase Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 UniQure N.V. Alpha N-Acetylglucosaminidase Product Portfolio
  6. 8.1.5 UniQure N.V. Recent Developments
  7. 8.2 Laboratorios Del Dr. Esteve S.A.
  8. 8.2.1 Laboratorios Del Dr. Esteve S.A. Company Information
  9. 8.2.2 Laboratorios Del Dr. Esteve S.A. Business Overview
  10. 8.2.3 Laboratorios Del Dr. Esteve S.A. Alpha N-Acetylglucosaminidase Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Laboratorios Del Dr. Esteve S.A. Alpha N-Acetylglucosaminidase Product Portfolio
  12. 8.2.5 Laboratorios Del Dr. Esteve S.A. Recent Developments
  13. 8.3 Dorphan S.A.
  14. 8.3.1 Dorphan S.A. Company Information
  15. 8.3.2 Dorphan S.A. Business Overview
  16. 8.3.3 Dorphan S.A. Alpha N-Acetylglucosaminidase Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Dorphan S.A. Alpha N-Acetylglucosaminidase Product Portfolio
  18. 8.3.5 Dorphan S.A. Recent Developments
  19. 8.4 BioMarin Pharmaceutical Inc.
  20. 8.4.1 BioMarin Pharmaceutical Inc. Company Information
  21. 8.4.2 BioMarin Pharmaceutical Inc. Business Overview
  22. 8.4.3 BioMarin Pharmaceutical Inc. Alpha N-Acetylglucosaminidase Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 BioMarin Pharmaceutical Inc. Alpha N-Acetylglucosaminidase Product Portfolio
  24. 8.4.5 BioMarin Pharmaceutical Inc. Recent Developments
  25. 8.5 Alexion Pharmaceuticals, Inc.
  26. 8.5.1 Alexion Pharmaceuticals, Inc. Company Information
  27. 8.5.2 Alexion Pharmaceuticals, Inc. Business Overview
  28. 8.5.3 Alexion Pharmaceuticals, Inc. Alpha N-Acetylglucosaminidase Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Alexion Pharmaceuticals, Inc. Alpha N-Acetylglucosaminidase Product Portfolio
  30. 8.5.5 Alexion Pharmaceuticals, Inc. Recent Developments
  31. 8.6 Abeona Therapeutics, Inc.
  32. 8.6.1 Abeona Therapeutics, Inc. Company Information
  33. 8.6.2 Abeona Therapeutics, Inc. Business Overview
  34. 8.6.3 Abeona Therapeutics, Inc. Alpha N-Acetylglucosaminidase Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Abeona Therapeutics, Inc. Alpha N-Acetylglucosaminidase Product Portfolio
  36. 8.6.5 Abeona Therapeutics, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Alpha N-Acetylglucosaminidase Value Chain Analysis
  2. 9.1.1 Alpha N-Acetylglucosaminidase Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Alpha N-Acetylglucosaminidase Production Mode & Process
  6. 9.2 Alpha N-Acetylglucosaminidase Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Alpha N-Acetylglucosaminidase Distributors
  9. 9.2.3 Alpha N-Acetylglucosaminidase Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst